Systemic Chemotherapy Interferes in Homocysteine Metabolism in Breast Cancer Patients

BACKGROUND: Hyperhomocysteinemia in breast cancer (BC) patients can be a risk factor for thromboembolic events. This study aimed to evaluate homocysteine and its cofators (folic acid and vitamin B12) concentrations and platelet count at diagnosis of BC, 3 and 6 months after the beginning of chemothe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Lab Anal
Hlavní autoři: Yamashita, Eliana K., Teixeira, Bianca M., Yoshihara, Renata N., Kuniyoshi, Renata K., Alves, Beatriz C.A., Gehrke, Flávia S., Vilas‐Bôas, Viviane A., Correia, João A., Azzalis, Ligia A., Junqueira, Virginia B.C., Pereira, Edimar Cristiano, Fonseca, Fernando L.A.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2014
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6807486/
https://ncbi.nlm.nih.gov/pubmed/24395112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.21660
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky